Related Experiment Video
Updated: May 19, 2026
05:48
Rapid Generation of Amyloid from Native Proteins In vitro
Published on: December 5, 2013
AA-Amyloid is cleared by endogenous immunological mechanisms
Sofia N Nyström1, Gunilla T Westermark
1Department of Clinical and Experimental Medicine, Division of Cell Biology, Linköping University, Linköping, Sweden.
Summary
The study shows that antibodies and macrophages help clear amyloid deposits in AA amyloidosis. This suggests immunoglobulins are key to amyloid degradation and resolution.
Area of Science:
- Immunology
- Pathology
- Biochemistry
Background:
- AA amyloidosis is a complication of chronic inflammatory diseases.
- Amyloid mass reduction occurs as inflammation subsides.
- Endogenous factors driving amyloid resolution are not well understood.
Purpose of the Study:
- To investigate the dynamics of amyloid degradation and resolution in experimental murine AA amyloidosis.
- To identify endogenous factors involved in amyloid clearance.
Main Methods:
- AA amyloidosis induced in mice using amyloid enhancing factor (AEF) and silver nitrate.
- Monitoring of amyloid deposit resolution over time.
- ELISA technique to detect anti-AA antibodies and macrophage phagocytosis assessment.
Main Results:
- Complete amyloid clearance observed within 34 weeks.
- Antibodies against protein AA detected during amyloid clearance.
- Macrophages shown to internalize amyloid deposits.
- Passive immunization with anti-amyloid monoclonal antibody reduced amyloid development.
Conclusions:
- Immunoglobulins co-localize with amyloid deposits.
- Fc-receptor mediated phagocytosis by macrophages contributes to amyloid degradation.
- Immunoglobulins are key players in the resolution of AA amyloidosis.
Related Concept Videos
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:31Antigen Processing Pathways
MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
MHC Class I: Presenting Endogenous...
01:26Antibody Actions
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...